Metabolic dysfunction-associated steatotic liver disease and gastroesophageal reflux disease: a mendelian randomization study in European and East Asian populations

被引:0
|
作者
Su, Chen'guang [1 ]
Liao, Zheng [1 ]
Li, Hewen [2 ]
Pei, Yinxuan [1 ]
Wang, Zixiang [1 ]
Li, Jian [1 ]
Liu, Jinlong [1 ,3 ]
机构
[1] Chengde Med Univ, Dept Hepatobiliary Surg, Affiliated Hosp, Chengde, Hebei, Peoples R China
[2] Chengde Med Univ, Dept Minimally Invas Spine Surg, Affiliated Hosp, Chengde, Hebei, Peoples R China
[3] Hebei Key Lab Panvasc Dis, Chengde, Hebei, Peoples R China
关键词
metabolic dysfunction-associated steatotic liver disease; gastroesophageal reflux disease; mendelian randomization; causal effect; genome-wide association studies; ALANINE AMINOTRANSFERASE; RISK-FACTORS; ESOPHAGITIS; PREVALENCE; OBESITY; INSTRUMENTS; SYMPTOMS; BIAS;
D O I
10.3389/fgene.2024.1428334
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background Numerous observational studies have shown a potential association between metabolic dysfunction-associated steatotic liver disease (MASLD) and gastroesophageal reflux disease (GERD). However, causality is unclear. This study utilized genome-wide association study (GWAS) genetic data to explore the causal relationship between MASLD and GERD in European and East Asian populations. Methods This study utilized a bidirectional, two-sample Mendelian randomization (MR) approach. All disease data were obtained from the GWAS database, and single nucleotide polymorphisms strongly associated with exposure were selected as instrumental variables. The inverse variance weighted (IVW) method is primarily utilized to evaluate the causal relationship between exposure and outcome. Finally, sensitivity analyses were performed to ensure the robustness of the results. Results The IVW estimates indicated that non-alcoholic fatty liver disease (NAFLD) (odds ratio (OR) = 1.054, 95% confidence interval (CI), 0.966-1.150, p = 0.236) and percent liver fat (OR = 0.977, 95% CI, 0.937-1.018, p = 0.258) in European population were not linked to a higher risk of GERD. However, GERD in European population was associated with an increased risk of NAFLD (OR = 1.485, 95% CI, 1.274-1.729, p < 0.001) and percent liver fat (OR = 1.244, 95% CI, 1.171-1.321, p < 0.001). In addition, the IVW analysis in East Asian population showed that alanine aminotransferase (ALT) was associated with an increased risk of GERD (OR = 2.305, 95% CI, 1.241-4.281, p = 0.008), whereas aspartate aminotransferase (AST) had no causal effects on GERD risk (OR = 0.973, 95% CI, 0.541-1.749, p = 0.926). Furthermore, the associations between GERD and ALT (OR = 1.007, 95% CI, 0.998-1.015, p = 0.123) or AST (OR = 1.004, 95% CI, 0.997-1.012, p = 0.246) were not significant. After removing outliers, a significant correlation between GERD and ALT was observed (OR = 1.009, 95% CI, 1.001-1.016, p = 0.020). Conclusion There was reverse causality between MASLD and GERD in European population, while there was bidirectional causality between a proxie for MASLD (ALT) and GERD in East Asian population. This study can provide novel insights into cross-ethnic genetic research on MASLD and GERD.
引用
收藏
页数:12
相关论文
共 50 条
  • [11] Retinopathy in Metabolic Dysfunction-Associated Steatotic Liver Disease
    Orfanidou, Myrsini
    Polyzos, Stergios A.
    MEDICINA-LITHUANIA, 2025, 61 (01):
  • [12] Metabolic Dysfunction-Associated Fatty Liver Disease Increases the Risk of Gastroesophageal Reflux Symptoms
    He, Yuan
    Duan, Zhi-Jun
    Wang, Cheng-Fang
    Wei, Yu-Shan
    Cai, Ming-Xu
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2022, 15 : 199 - 207
  • [13] Causal relationship between depression and metabolic dysfunction-associated steatotic liver disease: a bidirectional Mendelian randomized study
    Liang, Weiyu
    Zhong, Kunting
    Lai, Tingting
    Zeng, Yuhao
    Huang, Zhanhui
    Zhou, Jiqing
    Huang, Jin
    Shi, Zhenni
    Zhang, Jin
    Ding, Fuping
    FRONTIERS IN PSYCHIATRY, 2024, 15
  • [14] Metabolic dysfunction-associated steatotic liver disease in children
    Goyal, Nidhi P.
    Xanthakos, Stavra
    Schwimmer, Jeffrey B.
    GUT, 2025, : 669 - 677
  • [15] Associations of cholecystectomy with the risk of gastroesophageal reflux disease: a Mendelian randomization study
    Qian, Jin
    Xu, Huawei
    Liu, Jun
    Zheng, Yihu
    INTERNATIONAL JOURNAL OF SURGERY, 2024, 110 (10) : 6836 - 6840
  • [16] Causal associations of metabolic dysfunction-associated steatotic liver disease with gestational hypertension and preeclampsia: a two-sample Mendelian randomization study
    Zhang, Lu
    Fang, Liang
    Zou, Jiahua
    Zhou, Dong
    Xie, Haonan
    Chen, Aihua
    Wu, Qingming
    HYPERTENSION IN PREGNANCY, 2025, 44 (01)
  • [17] Sex differences in metabolic dysfunction-associated steatotic liver disease: a narrative review
    Joo, Sae Kyung
    Kim, Won
    EWHA MEDICAL JOURNAL, 2024, 47 (02):
  • [18] Genetically predicted metabolites mediate the association between immune cells and metabolic dysfunction-associated steatotic liver disease: a mendelian randomization study
    Ye, Dan
    Wang, Jiaofeng
    Shi, Jiaheng
    Ma, Yiming
    Chen, Jie
    Hu, Xiaona
    Bao, Zhijun
    LIPIDS IN HEALTH AND DISEASE, 2024, 23 (01)
  • [19] Gastroesophageal reflux disease and oral symptoms: A two-sample Mendelian randomization study
    Jiang, Shijing
    Zheng, Liang
    Miao, Zhiwei
    FRONTIERS IN GENETICS, 2023, 13
  • [20] A Mendelian randomization analysis identifies causal association between sarcopenia and gastroesophageal reflux disease
    Hu, Renwang
    Liu, Can
    Li, Dan
    AGING-US, 2024, 16 (05):